UALink Optimism Doesn't Mask Margin Risks

What happened

A Zacks article highlights Astera Labs' UALink 2.0 push and Scorpio switch expansion as AI infrastructure growth drivers, with deployments expected in 2027. However, the latest DeepValue Master Report maintains a WAIT rating, citing Q2'26 gross margin guidance down to ~73% from 76.3% in Q1'26 and extreme customer concentration (five direct customers make up 90% of revenue). The positive UALink narrative does not address the near-term headwinds from commercial concessions and the 200 bps non-cash impact from a customer agreement. The thesis remains dependent on proof of margin stabilization and Scorpio's 2H'26 production ramp, both of which are unconfirmed. Thus, the bullish catalyst is acknowledged but not yet actionable given the valuation at 166.8x P/E.

Implication

The UALink catalyst is real but years away; near-term focus should be on Q2'26 gross margin (~73% guided) and customer concentration. If margins recover to 75%+ and Scorpio X ramps as guided in 2H'26, the stock could re-rate. But with insider selling concentrated in March–April and a customer warrant capping economics, the risk/reward is unattractive until concrete evidence of execution emerges. A disciplined entry near $180 (the report's attractive entry) offers better asymmetry.

Thesis delta

The UALink article reinforces the long-term opportunity but does not alter the near-term WAIT thesis. The report's concerns about margin compression and customer concentration remain the dominant drivers. The thesis is unchanged: the stock prices perfection, but the Q2 guide shows cracks.